Skip to main content

Animations

MJFF Publications

4071 - 4080 of 6509 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: Genetic risk factor clustering within and across neurodegenerative diseases
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad161
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-023-06956-w
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Adaptor protein-3 produces synaptic vesicles that release phasic dopamine
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2309843120
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Evaluation of an Adapted Semi-Automated DNA Extraction for Human Salivary Shotgun Metagenomics
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/biom13101505
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Magnetic Resonance Imaging Biomarkers of Punding in Parkinson’s Disease
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci13101423
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Damaged mitochondria recruit the effector NEMO to activate NF-κB signaling
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2023.08.005
    Citation Count: 80
  • Summary Details
    OPEN
    Title: No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106243
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2302720120
    Citation Count: 47
  • Summary Details
    OPEN
    Title: PARK15 / FBXO7 is dispensable for PINK1 /Parkin mitophagy in iNeurons and HeLa cell systems
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by
    DOI - Digital Object Identifier: 10.15252/embr.202256399
    Citation Count: 31
  • Summary Details
    OPEN
    Title: A fluid-walled microfluidic platform for human neuron microcircuits and directed axotomy
    Journal Name: Lab on a Chip
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1039/d4lc00107a
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.